LifeStance Health Group (LFST)
(Delayed Data from NSDQ)
$5.23 USD
-0.14 (-2.61%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $5.22 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Fundamental Charts
About Return on Equity (TTM)
LifeStance Health Group, Inc.'s return on equity, or ROE, is -1.11% compared to the ROE of the Medical - Outpatient and Home Healthcare industry of 8.78%. While this shows that LFST has struggled to make solid use of its equity, this metric will vary significantly from industry to industry.
Return on Equity (or ROE) is calculated as income divided by average shareholder equity (past 12 months, including reinvested earnings). The income number is listed on a company's Income Statement. Shareholder Equity (which is the difference between Total Assets and Total Liabilities) can be found on the Balance Sheet.
LFST 5.23 -0.14(-2.61%)
Will LFST be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LFST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFST
LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates
Bet on 5 Top-Ranked Stocks With Rising P/E
LFST: What are Zacks experts saying now?
Zacks Private Portfolio Services
LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?
After Plunging 9.9% in 4 Weeks, Here's Why the Trend Might Reverse for LifeStance Health (LFST)
Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet
Other News for LFST
20 Day Moving Average Resistance appears for LFST after 2.61% move
LFST forms Stochastic Buy Signal on September 18
Lower Bollinger Band Walk appears for LFST after 1.53% move
TPG GP A, LLC Reduces Stake in Life Time Group Holdings Inc
Bullish Engulfing appears for LFST after 0.97% move